Cramer's top biotech with enormous value creation By: CNBC.com News January 15, 2015 at 18:42 PM EST This biotech just upped its guidance for 2015. Jim Cramer thinks it could have a lot more in the pipeline for profits. Read More >> Related Stocks: Biomarin Pharmaceuticals Shire Plc Ads